Livestream: On the Hot Seat: An Immersive Course for Optimizing PET Imaging in Early Alzheimer’s Disease

Traditional diagnosis and treatment of Alzheimer’s disease (AD) has relied heavily on the clinical expertise of healthcare professionals (HCPs) and patient-reported symptoms. However, recently revised diagnostic criteria incorporate biomarkers—such as amyloid and tau pathology—and advanced imaging modalities, including amyloid, tau, and fluorodeoxyglucose (FDG) positron emission tomography (PET) scans, to enhance early detection and determine eligibility for targeted therapies. Imaging clinicians in nuclear medicine, as part of the multidisciplinary team, would benefit from education on best practices for the use, interpretation, and reporting of PET imaging to support timely and accurate diagnosis and guide treatment decisions.

In this Efficient CME livestream symposium, expert faculty will examine and share best practices for interpreting and reporting PET imaging in early AD and provide opportunities to test your skills using a highly interactive format to help improve real-world practices.

At the conclusion of this activity, learners will be able to better:

• Assess the optimal use of biomarkers to facilitate the early diagnosis of AD
• Implement best practices for the use, interpretation, and reporting of amyloid PET imaging to ensure accurate diagnosis of AD and eligibility for targeted treatment
• Identify the roles of tau PET and FDG PET in the evaluation of patients suspected of early-stage AD to more effectively contextualize their interpretation and reporting

This program is supported by an independent educational grant from Lilly.

Imaging clinicians including nuclear medicine physicians, radiologists, neuroradiologists, radiology physician associates (PAs), nurse practitioners (NPs), imaging residents and other healthcare professionals involved in the diagnosis of patients with AD pathology

It is the policy of CME Outfitters, LLC, to ensure independence, balance, objectivity, and scientific rigor and integrity in all of their CE activities. Faculty must disclose to the participants any relationships with commercial companies whose products or devices may be mentioned in faculty presentations, or with the commercial supporter of this CE activity. CME Outfitters, LLC, has evaluated, identified, and mitigated any potential conflicts of interest through a rigorous content validation procedure, use of evidence-based data/research, and a multidisciplinary peer review process. The following information is for participant information only. It is not assumed that these relationships will have a negative impact on the presentations.

Dr. Franceschi reports the following financial relationships:

Consultant: Biogen; Blue Earth Diagnostics; Cortechs.ai; Eisai Inc.; icometrix; Life Molecular Imaging Ltd.; Lilly; MIM Software Inc.; Cardinal Health; Roche/Genentech, Inc.; Siemens Healthineers; and Springer Nature

The following individuals have no financial relationships to disclose:

Rebecca Vargas-Jackson, MD (Peer Reviewer)
Albert Eubanks, Jr., RN (Peer Reviewer)
Mary Gleason, PhD, CHCP (Planning Committee)
Nichole Lainhart (Planning Committee)
Estelle Perera (Planning Committee)
Scott J. Hershman, MD, FACEHP, CHCP (Planning Committee)
Sandra Caballero, PharmD (Planning Committee)
Sharon Tordoff (Planning Committee)

*All identified conflicts of interest have been mitigated.

Unlabeled Use Disclosure
Faculty of this CME/CE activity may include discussions of products or devices that are not currently labeled for use by the FDA. The faculty have been informed of their responsibility to disclose to the audience if they will be discussing off-label or investigational uses (any uses not approved by the FDA) of products or devices. CME Outfitters, LLC, the faculty, planners, and reviewers do not endorse the use of any product outside of the FDA labeled indications. Medical professionals should not utilize the procedures, products, or diagnosis techniques discussed during this activity without evaluation of their patient for contraindications or dangers of use.

Post-tests, credit request forms, and activity evaluations must be completed online (requires free account activation), and participants can print their certificate or statement of credit immediately (0% pass rate required). This website supports all browsers except Internet Explorer for Mac.

Call us at 877.CME.PROS (877.263.7767).

MMS-157-062225-11